ICD-10-CM Billable Code

T37.2X6

Underdosing of antimalarials and drugs acting on other blood protozoa

Clinical Classification Guidelines

Medical Intelligence & Overview

The ICD-10 code T37.2X6 refers to cases where there is an underdosing of medications used to treat malaria and other blood protozoan infections. Under-dosing happens when the prescribed medication amount or frequency is less than what is recommended for effective treatment. This can occur intentionally or unintentionally and can have significant impacts on treatment success, leading to persistent infection or drug resistance.

Causes & Symptoms

Clinical Causes: Lack of patient adherence to prescribed medication regimen Incorrect dosage prescribed by healthcare providers Misunderstanding of dosing instructions Medication shortages or availability issues Intentional reduction of dose due to side effects or perceived toxicity Delay in therapy initiation or missed doses

Key Symptoms: Persistent or recurrent symptoms of malaria or protozoal infection, such as fever, chills, and sweats Incomplete resolution of infection despite treatment Possible signs of drug resistance, like ongoing parasitemia Adverse effects resulting from improper dosing, such as toxicity or treatment failure General fatigue and weakness associated with ongoing infection

Diagnostic & Treatment

Diagnosis Path: Diagnosis involves reviewing the patient's medication history, verifying adherence to the prescribed dosing schedule, and conducting laboratory tests such as blood smears or molecular assays to detect ongoing parasitic presence. Healthcare providers also assess clinical symptoms and may perform additional tests to rule out drug resistance.

Treatment Protocols: Addressing underdosing involves ensuring proper medication adherence, adjusting doses if necessary, and monitoring the patient closely. Healthcare providers may recommend patient education about correct medication use, reinforce the importance of completing therapy, and consider alternative treatment options if resistance or side effects are suspected. Regular follow-up and laboratory testing are vital to confirm clearance of the infection.

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is T37.2X6 a billable ICD-10 code?
Yes, T37.2X6 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report T37.2X6?
Clinical documentation must specify the nature of Underdosing of antimalarials and drugs acting on other blood protozoa and any associated comorbidities for accurate reporting.

Cite this Clinical Reference